Full Press Release Details
SS Innovations to Host SMRSC 2026 in New Delhi,
India from April 9-11, 2026
Conference to Unite Global Leaders at the Forefront
of Surgical Robotic Innovation
Lauderdale, FL - April 7, 2026 - SS Innovations International, Inc. (the "Company" or "SS
Innovations") (Nasdaq: SSII), a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable
and accessible to a global population, today announced that the Company is hosting the Global Multi-Specialty Robotic Surgery Conference
("SMRSC 2026") in New Delhi, India from April 9-11, 2026.
In this third installment of the event, SMRSC
2026 will bring together distinguished surgeons, global thought leaders and prominent innovators to discuss and shape the future of robotic
and minimally invasive surgery. Attendance at SMRSC 2026 is expected to surpass that of last year's conference, which drew more
than 1,400 attendees and 600 virtual participants from 17 nations.
Among this year's conference highlights:
Dr. Sudhir Srivastava, Chairman of the Board and
Chief Executive Officer of SS Innovations, commented, "We are thrilled to host SMRSC 2026 this week in New Delhi, where global experts
in surgical robotic care will convene to discuss innovation and the future of our field. From live telesurgeries and robotic surgeries
to demonstrations of exciting new technologies, this year's event will be our largest and will continue to elevate the theme of
decentralizing and democratizing access to surgical robotic care."
SMRSC 2026 is a global multi-specialty
robotic surgery conference bringing together surgeons, innovators, educators, and healthcare leaders. The event will showcase live procedures,
innovation, panel discussions, presentations by distinguished guests, and professional collaboration to shape the future of robotic surgery.
learn more, please visit: https://ssinnovations.com/SMRSC_2026/about/.
register for the conference, please visit: https://ssinnovations.com/SMRSC_2026/register/.
About SS Innovations
SS Innovations International, Inc. (Nasdaq: SSII)
develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a
larger segment of the global population. The Company's product range includes its proprietary "SSi Mantra" surgical
robotic system and its comprehensive suite of "SSi Mudra" surgical instruments, which support a variety of surgical robotic
procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of
its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company's website at ssinnovations.com
or LinkedIn for more information and updates.
About the SSi Mantra
The SSi Mantra surgical robotic system is a user-friendly,
modular, multi-arm system with advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command
center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic
patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. The optional SSi MantrAsana Tele Surgeon
Console is a portable, compact alternative to the SSi Mantra's standard surgeon command center that provides equivalent control
functionality while enabling enhanced portability, ergonomic flexibility, and telesurgery capability. The SSi Mantra utilizes over 40
different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery, and 5mm instruments
for the pediatric population and ENT surgeries. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon
to provide better safety and efficiency. The SSi Mantra has been clinically validated in India in more than 100 different types of surgical
Forward Looking Statements
This press release may contain statements that
are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995.
The words "anticipate," "assume," "believe," "estimate," "expect," "will,"
"intend," "may," "plan," "project," "should," "could," "seek,"
"designed," "potential," "forecast," "target," "objective," "goal,"
or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future
events or SS Innovations' future financial performance and involve known and unknown risks, uncertainties and other factors that
may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels
of activity, performance or achievements expressed or implied by these forward-looking statements.
Devin Sullivan, Managing Director